期刊文献+

法舒地尔治疗继发性肺动脉高压疗效分析 被引量:5

下载PDF
导出
摘要 目的观察法舒地尔对慢性阻塞性肺疾病肺动脉高压的治疗效果。方法将120例慢性阻塞性肺疾病肺动脉高压患者随机分为对照组和治疗组,每组60例。对照组行常规治疗,治疗组在常规治疗的基础上加法舒地尔30mg入150ml0.9%氯化钠静脉滴注,1次/d,2组均给予吸氧、抗感染和强心利尿等对症治疗。14d后2组均停用抗生素,治疗组停用法舒地尔。治疗前后检查超声心动图测肺动脉压力,行血气分析测定氧分压(PaO2)及血氧饱和度(SaO2)。结果用药后2组PaO2及SaO2均升高,与用药前比较差异有统计学意义(P<0.05),治疗组升高幅度大于对照组(P<0.05),用药后治疗组肺动脉压明显降低,与用药前及对照组用药后比较差异有统计学意义(P<0.05)。结论法舒地尔治疗慢性阻塞性肺疾病引起的继发性肺动脉高压疗效确切。
出处 《河北医药》 CAS 2011年第4期541-542,共2页 Hebei Medical Journal
  • 相关文献

参考文献8

  • 1王秋芬,廖玉华.欧洲心脏病协会2004年肺动脉高压诊断和治疗指南简介[J].临床心血管病杂志,2005,21(7):385-386. 被引量:57
  • 2孙兴珍,田向阳.法舒地尔对大鼠低氧性肺动脉高压及其肺血管结构重建的影响[J].临床儿科杂志,2008,26(5):421-424. 被引量:8
  • 3Shiga N, Hirano K, Hirano M, et al. Long term inhibition of RhoA at tenuates vascular cont ractility "by enhancingendot helial NO production in an intact rabbit mesenteric arter. Circ Res,2005 ,96 :1014-1021.
  • 4Fagan KA, Oka M, Bauer NR, et al. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by in hibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol,2004,287:L656 -L664.
  • 5Nagaoka T, Morio Y, Casanova N, et al. Rho/Rho-kinase signalingme diates increased basal pulmonary vascular tone in chronically hypoxierats. Am J Physiol Lung Cell Mol Physiol,2004,287:665-672.
  • 6Nagaoka T,Fagan KA,Gebb SA,et al. Inhaled Rho kinase inhibitots are potent and selective varodilators in rat pulmonary hypertension. Am J Respir Cfit Care Med,2005 ,171:494-499.
  • 7Galie N, Torbicki A, Barst R, et al. Guidelines on the diagnosis and treatment of pulmonary arterial .hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the european society of cardiology. Eur Heart J,2004,25:2243-2278.
  • 8Wang ZQ, Jin N J, Ganguli S, et al. Rho-kinase activation is involved in hypoxia-induced pulmonary vasoconstriction. Am J Respir Cell Mol, 2001,25:628-635.

二级参考文献15

  • 1范瑾,杜军保,张春雨.长期雾化吸入硝酸甘油对高肺血流大鼠肺动脉压力及肺血管结构重建的影响[J].临床儿科杂志,2004,22(7):470-473. 被引量:5
  • 2薛全福,谢剑鸣.常压缺氧性大鼠肺动脉高压模型的建立[J].中华结核和呼吸杂志,1989,12(6):350-352. 被引量:157
  • 3李谧,周同甫,刘瀚旻,华益民,王献民,赵亮.洛沙坦对高肺血流量大鼠肺血管平滑肌增殖及肺小动脉重构的抑制作用[J].临床儿科杂志,2006,24(6):516-519. 被引量:3
  • 4Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine [J]. Arterioscle Thromb Vasc Biol,2005,25(9) : 1767-1775.
  • 5Fagan KA, Oka M, Bauer NR, et al. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase [J]. Am J Physiol Lung Cell Mol Physiol,2004,287 (4):L656- L664.
  • 6Nagaoka T, Morio Y, Casanova N, et al. Rho/Rho-kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats [J]. Am J Physiol Lung Cell Mol Physiol, 2004,287 (4) : L665-L672.
  • 7Nagaoka T,Fagan KA,Gebb SA,et al. Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension [J]. Am J Respir Crit Care Med, 2005,171 (5) :494-499.
  • 8Fukumoto Y, Matoba T, Ito A, et al. Acute vasodilator effects of a Rho-kinase inhibitor, fasudil,in patients with severe pulmonary hypertension [J]. Heart,2005,91 (3): 391-392.
  • 9Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension [J]. Circulation, 2004,109(2) : 159-165.
  • 10Stenmark KR, McMurtry IF. Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension:a time for reappraisal? [J]. Circ Res,2005,97 (2): 95-98.

共引文献61

同被引文献58

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部